IRC
PRTA icon

Investors Research Corp’s Prothena Corp PRTA Stock Holding History

Investors Research Corp’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4
Closed – – 1134
2022
Q1 		$0 Hold
4
– – ﹤0.01% 1077
2021
Q4 		$0 Hold
4
– – ﹤0.01% 1030
2021
Q3 		$0 Buy
+4
New +$248 ﹤0.01% 1025

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Investors Research Corp's PRTA Position: Q2 2022 in Review

Investors Research Corp sold out of Prothena Corp (PRTA) in Q2 2022, closing a stake of 4 shares.

Investors Research Corp first reported a position in PRTA in Q3 2021 and held it in 3 quarters. The position peaked at $0 in Q1 2022. 166 funds tracked by Wall St. Rank hold PRTA as of Q2 2022.

  • Investors Research Corp reported no remaining Prothena Corp position as of Q2 2022 after selling out during the quarter.
  • Investors Research Corp sold 4 Prothena Corp shares in Q2 2022.
  • Investors Research Corp first reported a position in Prothena Corp in Q3 2021 and held it in 3 quarters.
  • Investors Research Corp's Prothena Corp position peaked at $0 in Q1 2022.
  • 166 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2022.

Based on Investors Research Corp's 13F filing for Q2 2022, filed 21 Jul 2022.